Cleavable Polymer Coating for Specific Microbial Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current polymer coatings on medical implants and objects cannot specifically detect or differentiate microbial infections caused by specific microorganisms, such as Gram-positive bacteria, as they rely on general environmental changes like pH or temperature fluctuations, leading to non-specific antimicrobial agent release.

Innovation Solution

A polymer coating with a cleavage site specific to sortase enzymes produced by Gram-positive bacteria, allowing for the targeted release of diagnostic or therapeutic agents only when these bacteria are present, thereby indicating a specific microbial infection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If general environmental changes (pH, temperature) are used to trigger agent release, then the coating responds to any infection or inflammatory response, but the release is not specific to particular microorganisms leading to false positives

Engineering Contradiction:
Improveresponse to infectionVSAvoidspecificity of detection
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The coating incorporates a cleavage site with a specific amino acid sequence (LPXTG) that is recognized and cleaved only by sortase enzymes produced by Gram-positive bacteria. This localized specificity within the polymer structure allows the coating to distinguish between different microbial causes of infection, releasing agents only when the specific bacterial enzyme is present, thereby eliminating false positives from general inflammatory responses.

Inventive Principle:
Principle #3Local quality

2Reliability

If pH change is used as a trigger for agent release, then the coating can detect bacterial infection, but it cannot differentiate between specific microorganisms

Engineering Contradiction:
Improvedetection of infectionVSAvoidinformation about specific pathogen
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The sortase enzyme serves as a specific intermediary that mediates between the presence of Gram-positive bacteria and the release of diagnostic or therapeutic agents. The enzyme recognizes and cleaves the specific LPXTG sequence in the polymer coating, providing a direct link between the specific pathogen presence and the agent release mechanism, thereby preserving information about the specific causative organism.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If antimicrobial agents are released in response to general environmental changes, then treatment can be initiated, but false positives lead to unnecessary treatment

Engineering Contradiction:
Improvetreatment initiationVSAvoidaccuracy of treatment indication
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The polymer coating contains a specifically designed cleavage site with the amino acid sequence LPXTG, which is recognized and cleaved exclusively by sortase enzymes produced by Gram-positive bacteria. This localized specificity ensures that antimicrobial agents are released only when the specific bacterial enzyme is present, eliminating false positives from general inflammatory responses or other infections, thereby ensuring treatment is initiated only when truly indicated.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The coating enables specific detection and potential treatment of microbial infections by releasing diagnostic or therapeutic agents only in the presence of targeted bacteria, reducing false positives and improving infection monitoring and treatment efficacy.

Implementation Method 1

the first cleavage site is cleaved by a sortase enzyme specifically provided by a microbe belonging to a first group consisting of Gram positive bacteria

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Data Source

PatentEP3424540B1Cleavable coating material having microbial functionality
Publication Date: 2022.11.23 ORIGINAL G BV
  • EP3424540B1 patent drawingFigure 1~2
  • EP3424540B1 patent drawingFigure 3~5
  • EP3424540B1 patent drawingFigure 6~9

AI summary

The present invention relates to a polymer coating comprising a) one or more polymers, said polymers comprising a first cleavage site and b) a diagnostic agent that is non-covalently bound within the polymer coating, said diagnostic agent being releasable from said coating upon cleavage of said first cleavage site, the first cleavage site being cleaved by an enzyme specifically provided by a microbe belonging to a first group consisting of a limited number of microbial strains, species or genera, and not cleaved by any enzyme provided by any microbe not belonging to said first group, wherein cleavage of the said first cleavage site results in release of the said diagnostic agent from the coating, the release of said diagnostic agent being indicative for the presence of a microbe belonging to the said first group. Further, methods of preparing such a coating and methods of detecting a visualizing the presence of microbes are presented.